Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.

Majdi A, Aoudjehane L, Ratziu V, Islam T, Afonso MB, Conti F, Mestiri T, Lagouge M, Foufelle F, Ballenghien F, Ledent T, Moldes M, Cadoret A, Fouassier L, Delaunay JL, Aït-Slimane T, Courtois G, Fève B, Scatton O, Prip-Buus C, Rodrigues CMP, Housset C, Gautheron J.
J Hepatol. 2019 Nov 21. pii: S0168-8278(19)30678-6. doi: 10.1016/j.jhep.2019.11.008.